SCHEMBL943989

SCHEMBL943989

CC1CC(NC(=O)CCl)CC(C)(C)C1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.59
HTT P42858 1/20 0.58
TDP1 Q9NUW8 2/20 0.50
LMNA P02545 3/20 0.48
PPP1CA P62136 1/20 0.48
KDM4E B2RXH2 1/20 0.43
ATM Q13315 1/20 0.37
NPSR1 Q6W5P4 1/20 0.36
CPB2 Q96IY4 1/20 0.36
JAK2 O60674 1/20 0.35
RAB9A P51151 1/20 0.35
MTNR1A P48039 2/20 0.35
MTNR1B P49286 2/20 0.35
CFD P00746 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
PAK1 Q13153 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1554542 0.91 ALDH1A1 (0.51) ALDH1A1HTTTDP1LMNAPPP1CA
SCHEMBL9893133 0.85 ALDH1A1 (0.59) ALDH1A1HTTTDP1LMNAPPP1CA
SCHEMBL4228227 0.83 ALDH1A1 (0.58) ALDH1A1HTTTDP1LMNAPPP1CA
SCHEMBL14296414 0.80 ALDH1A1 (0.63) ALDH1A1HTTTDP1LMNAPPP1CA
SCHEMBL17728269 0.80 ALDH1A1 (0.54) ALDH1A1HTTTDP1LMNAPPP1CA
SCHEMBL2024842 0.79 ALDH1A1 (0.61) ALDH1A1HTTTDP1LMNAPPP1CA
SCHEMBL1555269 0.79 ALDH1A1 (0.61) ALDH1A1HTTTDP1LMNAPPP1CA
SCHEMBL1555271 0.79 ALDH1A1 (0.61) ALDH1A1HTTTDP1LMNAPPP1CA
SCHEMBL1555270 0.79 ALDH1A1 (0.61) ALDH1A1HTTTDP1LMNAPPP1CA
SCHEMBL7963467 0.77 ALDH1A1 (0.59) ALDH1A1HTTTDP1LMNAPPP1CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011000945-A9 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-04-07 WO disclosed
WO-2011000945-A2 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-01-06 WO disclosed